Livingston Mark S. sold $15K of PGNY
Livingston Mark S. (CHIEF FINANCIAL OFFICER) sold 599 shares of Progyny, Inc. (PGNY) at $25.50 on 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider activity for Progyny but does not introduce new operational, financial, or regulatory information.
Market read
Primarily a sentiment/positioning datapoint; typically low immediate trading impact due to 10b5-1 context.
What to watch
Traders may want to compare this sale against prior Form 4 activity (frequency, total sold over time) to judge whether it deviates from the plan’s typical cadence.
Background
This is an SEC Form 4 insider transaction: an officer (CFO) reports sale of company shares; the filing notes the transaction was executed under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Progyny CFO Livingston Mark sold 599 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosed on Form 4.
Likely limited near-term price impact; any effect would be second-order if selling accelerates beyond planned activity.
The filing provides a specific sale size and price, but 10b5-1 plans are designed to be non-informational, so the market typically discounts the signal.
Market effects
No clear sector read-through from a single CFO 10b5-1 sale.
None.
None.
Counterpoint
Even with 10b5-1, repeated or larger-than-usual insider sales can still influence sentiment if investors view it as a risk signal.
Key entities
- issuerProgyny, Inc.
Company whose CFO reported an open-market sale of shares under a pre-arranged 10b5-1 plan.
- officerLivingston Mark S.
Chief Financial Officer who sold 599 shares at $25.50 on June 4, 2026.
